Showing results (1001-1010 of 1,524) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2017
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction ModelsChunli Chen, Sebastian G Wicha, Gerjo J de Knegt, et al.CPT: Pharmacometrics & Systems Pharmacology|January 23, 2014
Mechanistic vs. Empirical network models of drug actionM R Birtwistle, D E Mager, J M GalloCPT: Pharmacometrics & Systems Pharmacology|January 24, 2014
The pharmacokinetics and pharmacokinetic/pharmacodynamic relationships of evacetrapib administered as monotherapy or in combination with statinsS Friedrich, J J P Kastelein, D James, et al.CPT: Pharmacometrics & Systems Pharmacology|April 27, 2023
Model-based approach to identify predictors of paclitaxel-induced myelosuppression in "real-world" administrationAhmed M Salem, Erik Dvergsten, Sanja Karovic, et al.CPT: Pharmacometrics & Systems Pharmacology|June 27, 2020
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future OpportunitiesNidal Al-Huniti, Yan Feng, Jingyu Jerry Yu, et al.CPT: Pharmacometrics & Systems Pharmacology|July 3, 2014
Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal ApproachesJ B Møller, N R Kristensen, S Klim, et al.CPT: Pharmacometrics & Systems Pharmacology|July 19, 2022
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitisAnita Moein, Tong Lu, Siv Jönsson, et al.CPT: Pharmacometrics & Systems Pharmacology|May 24, 2023
Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasmaYumi Yamamoto, Patricia Sanwald Ducray, Marcus Björnsson, et al.CPT: Pharmacometrics & Systems Pharmacology|February 10, 2023
N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysisEmma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.CPT: Pharmacometrics & Systems Pharmacology|February 17, 2023
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19Ryo Tamura, Kei Irie, Atsushi Nakagawa, et al.Pageof 153